Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Explore the best credit cards that earn the most points to maximize your rewards. Learn how to choose the right card for your spending habits.
25,897 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
A troubling case shows how unauthorized enrollment in life insurance can unfold. Learn how the scheme worked, red fla...
With July 7 approaching, many investors wonder if SpaceX is a buy. This guide breaks down the key catalysts, risks, a...
Investors can access retirement funds before 59½ without the 10% penalty if they follow the Substantially Equal Perio...
RLUSD activity is rising in enterprise payments, fueling a debate about whether ripple’s rlusd replacing xrp? is poss...
When celebrities host high-profile weddings, their music choices often spark trend waves. Learn how a memorable aisle...
Meta is pursuing a bold, dual-track strategy: build massive data centers to fuel AI workloads while exploring a poten...
A new wave of defense investing is shifting capital away from traditional U.S. contractors toward allied and private ...
XRP fell near $1.08 as big-money moves on the XRP Ledger quieted and ETF flows turned negative, underscoring a cautio...
Meta Platforms is gaining momentum in July 2026 as advertisers lean into AI-powered targeting. This piece explains wh...
As Anthropic eyes an IPO, a potential $1.2 trillion valuation could ripple through AI stocks. This piece breaks down ...
A major Vanguard growth ETF is underperforming the S&P 500 this year. Here's how concentration in mega-cap tech shape...